Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0000950170-25-113800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | TEVA | McAvoy David R. | EVP, CLO | P - Purchase | $18.86 | +1,113 | 13.0K | +9% | +$21.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-09-05 | P | A | 1,113 | $18.86 | 13,027 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |